Sagent Pharmaceuticals, Inc.: key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2015)
- $318.3M
- Net Income/Loss (FY2015)
- -$21.9M
- Total Assets (FY2015)
- $349.7M
- Total Equity (FY2015)
- $251.1M
- Cash Flows from Operating Activities (FY2015)
- -$7.5M
Source: Sagent Pharmaceuticals, Inc. 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
